Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 3
1965 1
1973 1
1974 7
1975 40
1976 68
1977 95
1978 61
1979 99
1980 93
1981 80
1982 105
1983 124
1984 109
1985 83
1986 105
1987 69
1988 72
1989 60
1990 77
1991 76
1992 65
1993 86
1994 93
1995 82
1996 97
1997 89
1998 80
1999 117
2000 129
2001 146
2002 151
2003 176
2004 176
2005 175
2006 162
2007 209
2008 201
2009 190
2010 215
2011 247
2012 217
2013 189
2014 202
2015 224
2016 171
2017 146
2018 151
2019 126
2020 151
2021 131
2022 89
2023 47
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

5,599 results

Results by year

Filters applied: . Clear all
Page 1
Vidarabine (Vira-A).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1977 May 20;19(10):42-3. Med Lett Drugs Ther. 1977. PMID: 323676 Clinical Trial. No abstract available.
Vidarabine ophthalmic ointment (Vira-A).
[No authors listed] [No authors listed] Drug Ther Bull. 1979 May 25;17(11):43-4. Drug Ther Bull. 1979. PMID: 467237 No abstract available.
Fludarabine: a review.
Hood MA, Finley RS. Hood MA, et al. DICP. 1991 May;25(5):518-24. doi: 10.1177/106002809102500512. DICP. 1991. PMID: 2068837 Review.
Cytarabine is used principally as an antileukemic agent, and vidarabine as an antiviral. Unlike vidarabine, fludarabine is resistant to deactivation by adenosine deaminase. ...
Cytarabine is used principally as an antileukemic agent, and vidarabine as an antiviral. Unlike vidarabine, fludarabine is res …
Vidarabine is neither a potent nor a selective AC5 inhibitor.
Seifert R. Seifert R. Biochem Pharmacol. 2014 Feb 15;87(4):543-6. doi: 10.1016/j.bcp.2013.12.025. Epub 2014 Jan 4. Biochem Pharmacol. 2014. PMID: 24398424 Review.
Therefore, vidarabine has been suggested to mediate these effects via selective inhibition of AC5. ...Here, evidence is presented that vidarabine is neither a potent nor a selective AC5 inhibitor. Greatest caution should be exerted when proposing new mechanisms of a …
Therefore, vidarabine has been suggested to mediate these effects via selective inhibition of AC5. ...Here, evidence is presented tha …
Oral fludarabine.
Plosker GL, Figgitt DP. Plosker GL, et al. Drugs. 2003;63(21):2317-23. doi: 10.2165/00003495-200363210-00004. Drugs. 2003. PMID: 14524733 Review.
5,599 results